Ignite Creation Date:
2024-10-25 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06569524
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-22
Brief Title:
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection TQA2225AP025 in Adult Subjects With Non-alcoholic Steatohepatitis NASH
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Double-blind Placebo RandomizedPhase II Study to Evaluate the Efficacy and Safety of TQA2225AP025 in Adults With Nonalcoholic Steatohepatitis NASH
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A randomized double-blind placebo-controlled Phase II studyto evaluate the efficacy and safety of TQA2225AP025 in Patients With Non-Alcoholic Steatohepatitis NASH
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None